These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 7549902

  • 1. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
    Lauria F, Raspadori D, Ventura MA, Rondelli D, Testoni N, Tosi P, Michieli M, Damiani D, Motta MR, Tura S.
    Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902
    [Abstract] [Full Text] [Related]

  • 2. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA.
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [Abstract] [Full Text] [Related]

  • 3. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG, Chen XM, Zhu HL, Zhong L, Zeng TT, Jia YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X.
    Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G.
    Leukemia; 1994 Mar 01; 8(3):388-94. PubMed ID: 7907393
    [Abstract] [Full Text] [Related]

  • 6. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb 01; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 01; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
    Gu LJ, Tie LJ, Jiang LM, Chen J, Pan C, Dong L, Chen J, Xue HL, Tang JY, Wang YP, Ye H.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr 01; 11(4):241-5. PubMed ID: 19374802
    [Abstract] [Full Text] [Related]

  • 9. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J, López-Karpovitch X, Cárdenas MR.
    Rev Invest Clin; 1997 Apr 01; 49(6):457-64. PubMed ID: 9528305
    [Abstract] [Full Text] [Related]

  • 10. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Am J Hematol; 2005 May 01; 79(1):26-35. PubMed ID: 15849776
    [Abstract] [Full Text] [Related]

  • 11. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb 01; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 12. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
    Drexler HG, Thiel E, Ludwig WD.
    Leukemia; 1993 Apr 01; 7(4):489-98. PubMed ID: 7681917
    [Abstract] [Full Text] [Related]

  • 13. [Cytomorphology of acute mixed leukemia].
    Sucić M, Batinić D, Zadro R, Mrsić S, Labar B.
    Acta Med Croatica; 2008 Oct 01; 62(4):379-85. PubMed ID: 19205415
    [Abstract] [Full Text] [Related]

  • 14. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C.
    Cancer Genet Cytogenet; 2004 Nov 01; 155(1):47-56. PubMed ID: 15527902
    [Abstract] [Full Text] [Related]

  • 15. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M.
    Haematologica; 1998 May 01; 83(5):392-7. PubMed ID: 9658721
    [Abstract] [Full Text] [Related]

  • 16. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J, Shao ZH, Liu H, Bai J, Cao YR, He GS, Tu MF, Wang XL, Hao YS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 Jul 01; 117(7):963-7. PubMed ID: 15265365
    [Abstract] [Full Text] [Related]

  • 17. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Jul 01; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 18. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E, Casasnovas RO, Campos L, Béné MC, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N.
    Leukemia; 1992 May 01; 6(5):393-9. PubMed ID: 1375696
    [Abstract] [Full Text] [Related]

  • 19. Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients.
    Daneshbod Y, Amirghofran Z, Tabei SZ.
    Neoplasma; 2005 May 01; 52(2):109-14. PubMed ID: 15800708
    [Abstract] [Full Text] [Related]

  • 20. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, Bernier M, Falkenrodt A, Lecalvez G, Maynadié M, Béné MC.
    Leukemia; 2003 Mar 01; 17(3):515-27. PubMed ID: 12646939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.